Society for Essential Health Action and Training, New Delhi, India Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2010
NCT00717730
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Society for Essential Health Action and Training

Active Ingredients

Drugs in Phase 2 Trials (2)

cyanocobalamin (berocca) (1 trial)

folic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 2)

Pneumonia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2